Genecare Development Limited reduced its holdings of Jieankang-B (02617) by 467,500 shares at a price of approximately HK$12.58 per share

Zhitongcaijing · 2d ago

The Zhitong Finance App learned that the latest data from the Hong Kong Stock Exchange shows that on August 5, Genecare Development Limited reduced its holdings of Pharmaceutical Jieankang-B (02617) by 467,500 shares, at a price of HK$125,786 per share, for a total amount of about HK$5.885 million. After the holdings were reduced, the latest number of shares held was approximately 21.4929 million shares, and the latest shareholding ratio was 6.87%.

This transaction involves other related parties: Tan Qingfen Chen, Ghalibo (PTC) Limited, Morningside Holdings (Asia) Limited, Morningside Bio-Ventures Limited, and Morningside Venture (I) Investments Limited.